Biocardia Inc (BCDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,496 | 2,371 | 1,103 | 7,363 | 12,872 |
| Receivables | 20 | N/A | 63 | 201 | 147 |
| TOTAL | $2,732 | $2,622 | $1,461 | $7,864 | $13,481 |
| Non-Current Assets | |||||
| PPE Net | 16 | 33 | 94 | 170 | 182 |
| Other Non-Current Assets | 665 | 1,069 | 1,432 | 1,759 | 2,055 |
| TOTAL | $681 | $1,102 | $1,526 | $1,929 | $2,237 |
| Total Assets | $3,413 | $3,724 | $2,987 | $9,793 | $15,718 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 641 | 385 | 890 | 683 | 507 |
| Accrued Expenses | 1,349 | 1,551 | 2,385 | 2,246 | 2,121 |
| TOTAL | $2,432 | $2,321 | $3,608 | $3,585 | $3,712 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 341 | 847 |
| Other Non-Current Liabilities | 86 | 566 | 982 | 1,316 | 1,631 |
| TOTAL | $86 | $566 | $982 | $1,316 | $1,631 |
| Total Liabilities | $2,518 | $2,887 | $4,590 | $4,901 | $5,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,940 | 4,680 | 1,783 | 1,346 | 1,125 |
| Common Shares | 11 | 5 | 2 | 20 | 17 |
| Retained earnings | -168,349 | -160,121 | -152,175 | -140,604 | -128,697 |
| TOTAL | $895 | $837 | $-1,603 | $4,892 | $10,375 |
| Total Liabilities And Equity | $3,413 | $3,724 | $2,987 | $9,793 | $15,718 |